MAM
EDIT icon

Martingale Asset Management’s Editas Medicine EDIT Stock Holding History

Martingale Asset Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-27,120
Closed -$92.5K – 784
2024
Q3 		$92.5K Hold
27,120
– – ﹤0.01% 782
2024
Q2 		$127K Hold
27,120
– – ﹤0.01% 774
2024
Q1 		$201K Hold
27,120
– – ﹤0.01% 780
2023
Q4 		$275K Buy
27,120
+100
+0.4% +$878 0.01% 717
2023
Q3 		$211K Buy
27,020
+6,600
+32% +$56.6K ﹤0.01% 743
2023
Q2 		$168K Hold
20,420
– – ﹤0.01% 776
2023
Q1 		$148K Buy
20,420
+4,102
+25% +$36.5K ﹤0.01% 794
2022
Q4 		$145K Buy
+16,318
New +$179K ﹤0.01% 811
2018
Q2 		– Sell
-7,116
Closed -$236K – 983
2018
Q1 		$236K Sell
7,116
-3
-0% -$107 ﹤0.01% 902
2017
Q4 		$219K Buy
+7,119
New +$179K ﹤0.01% 916

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Martingale Asset Management's EDIT Position: Q4 2024 in Review

Martingale Asset Management sold out of Editas Medicine (EDIT) in Q4 2024, closing a stake of 27,120 shares — an estimated $92.5K sold.

Martingale Asset Management first reported a position in EDIT in Q4 2017 and held it in 10 quarters. The position peaked at $275K in Q4 2023. 206 funds tracked by Wall St. Rank hold EDIT as of Q4 2024.

  • Martingale Asset Management reported no remaining Editas Medicine position as of Q4 2024 after selling out during the quarter.
  • Martingale Asset Management sold 27,120 Editas Medicine shares in Q4 2024, an estimated $92.5K.
  • Martingale Asset Management first reported a position in Editas Medicine in Q4 2017 and held it in 10 quarters.
  • Martingale Asset Management's Editas Medicine position peaked at $275K in Q4 2023.
  • 206 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2024.

Based on Martingale Asset Management's 13F filing for Q4 2024, filed 13 Feb 2025.